Medtronic Reports Nearly Double-Digit Revenue Growth in Q4 FY26
Medtronic reported $9.8 billion in revenue for its fiscal fourth quarter, representing nearly 10% year-over-year growth and exceeding expectations. The company's cardiovascular unit drove performance with a 13.8% increase to $3.8 billion, while cardiac ablation solutions saw global sales rise by 78%, including a significant jump of 124% in the U.S.
